WS #13309
Holding: newest synthesis is 100d 9h old
AstraZeneca is in talks to acquire Bristol Myers Squibb, sending AZN shares down 7% and likely boosting BMY, with implications for the pharma sector.
Pharma M&A: AstraZeneca-Bristol Myers talks
AstraZeneca is in talks to acquire Bristol Myers Squibb, sending AZN shares down 7% and likely boosting BMY, with implications for the pharma sector.